Menu
Washingtoner
  • Home
  • Artificial Intelligence
  • Health
  • Technology
  • Entertainment
  • Software
  • Business
  • Education
  • Real Estate
Washingtoner

Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
Washingtoner/10338857

Trending...
  • New Self-Service Sandbag Station at Tacoma Recovery and Transfer Center
  • The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
  • City of Spokane and City Council Announce 2027 Legislative Priorities
Sibannac, Inc. (Stock Symbol: SNNC) Sibannac, Inc. (Stock Symbol: SNNC) $SNNC Sibannac, Inc. (OTC PINK: SNNC) $SNNC Corporate Ads
$SNNC acquires Majority Stake in New Joint Venture With Doc-Rx Opens the Door to Telehealth, U.S.-Made Peptides and an Ambitious Wellness Clinic Expansion Strategy

PHOENIX - Washingtoner -- Sibannac, Inc. (OTC PINK: SNNC) $SNNC is advancing its wellness growth strategy with a significant announcement that introduces a new platform for potential business expansion. The company announced today that it holds a 51% majority interest in Apollo Wellness Centers, Inc., a newly formed joint venture with Doc-Rx.com, LLC. The initiative combines an established telehealth platform, relationships with partner compounding pharmacies, a U.S.-based peptide supply chain and plans to develop a network of branded wellness clinics.

For SNNC investors, this development represents an important addition to the company's business portfolio and creates a new opportunity to participate in the expanding market for medically supervised wellness services.

The strategy is particularly interesting because Apollo is designed to build upon infrastructure that Doc-Rx already operates. Rather than beginning with an entirely new technology platform, the venture intends to use existing capabilities as a foundation for developing its own branded clinic network and additional wellness offerings.

With Sibannac holding the majority interest, the company is positioning Apollo as a potential contributor to its broader growth ambitions.

A Major New Development for Sibannac Shareholders

The October 27 announcement confirms Sibannac's 51% ownership interest in Apollo Wellness Centers under a joint venture agreement dated October 1, 2026.

This majority position gives Sibannac the controlling ownership interest in the new venture, while Doc-Rx serves as its strategic partner.

Apollo's initial platform includes several complementary capabilities:
  • Telehealth services: Online consultations through licensed healthcare professionals.
  • Pharmacy partnerships: Relationships with partner 503A compounding pharmacies supporting prescriptions from licensed prescribers.
  • U.S.-based peptide supply chain: Domestic sourcing and production capabilities described by the companies as extending from raw materials through finished products.
  • Health tracking: Technology intended to support the broader wellness services offering.
  • Branded clinic development: A planned network of Apollo Wellness Centers locations through a licensing model.

Together, these elements give Apollo a foundation from which to pursue a broader wellness business. The company's immediate opportunity is to organize these capabilities under one brand and develop a scalable commercial model.

Apollo Wellness Centers: A Platform Designed for Expansion

One of the most compelling elements of the announcement is Apollo's proposed clinic licensing strategy.

More on Washingtoner
  • A Diwali Celebration with Heritage at South Brunswick Residents & American Properties
  • Law Offices of Larry E. Bray, P.A. Wins Fourth District Appeal Clarifying Limits of Florida's Offer of Judgment Statute
  • Holiday Magic Returns to Downtown Downers Grove November 27-29
  • What If the Greatest Gift This Holiday Season Came in a Dream of Your Loved One in Spirit?
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Minneapolis

The company expects wellness clinics operating under the Apollo Wellness Centers brand to become its largest source of revenue. Under the proposed model, licensed prescribers would own individual clinics, license the Apollo brand and order through Doc-Rx.

This approach is intended to enable the brand to expand without requiring Apollo itself to own every physical location.

For Sibannac, the model offers an opportunity to develop a broader business presence through partnerships with licensed healthcare professionals. As the network grows, Apollo could potentially benefit from increased brand recognition, participation in its supporting platform and additional commercial activity associated with its services.

The initial focus will be on translating the platform into operational clinics and establishing the relationships needed to support expansion.

Although the company has not announced a specific number of locations or a clinic-opening timetable, the licensing strategy establishes a clear direction for Apollo's development.

Doc-Rx Adds Existing Technology and Healthcare Relationships

Doc-Rx is central to the venture's strategy because it brings an operating telehealth platform and existing relationships with partner pharmacies.

The platform connects licensed clinicians with patients through online consultations, with prescriptions handled through partner pharmacies when appropriate. Its health-tracking capabilities also complement the broader concept of personalized, professionally supervised wellness.

The companies describe the peptide supply chain as U.S.-based, covering the process from domestic raw materials through synthesis and compounding.

These capabilities give Apollo a starting point for developing its branded clinic network and exploring additional services.

For investors, the combination of Sibannac's majority ownership and Doc-Rx's existing platform creates a strategic opportunity to develop a new wellness business without having to construct every component independently.

Additional Growth Opportunities in Products and Telemedicine

Apollo's ambitions extend beyond physical wellness clinics.

The joint venture also plans to develop its own product line, potentially including peptides, nutraceuticals and medical foods, alongside expanded telemedicine services.

These planned offerings could complement the clinic network and create additional opportunities for brand development over time.

A combined approach incorporating clinics, telehealth and wellness products could allow Apollo to pursue several related areas of the market through a coordinated business strategy.

For Sibannac, this creates an opportunity to broaden its participation in the wellness sector while developing another business platform alongside its existing portfolio.

Product launches expanded services and future clinic development remain important milestones to watch as the venture progresses.

More on Washingtoner
  • LGF Lab Gas Flow Launches Fully Automatic Laboratory Gas Changeover Manifold System with Ultra High Purity Gas Regulator Valve
  • Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
  • Inaugural 12 Trees of Christmas gala raises $525,000 for DMG research and family support
  • BitTitan Expands MigrationWiz with SharePoint Sites Migration and Simplified Collaboration Licensing
  • Olympic champion Katie Moon to compete at Pole Vault in Paradise in Key West

Building on Sibannac's Broader Wellness Vision

Sibannac has described its strategy as building a portfolio of wellness businesses, emerging consumer brands, product-development capabilities and strategic partnerships.

Earlier in 2026, the company announced initiatives involving functional mushroom and moringa products, as well as a proposed joint venture to develop a compliant psilocybin research facility. In August, Sibannac also announced a non-binding letter of intent concerning a potential strategic collaboration and transaction focused on patient health.

Those initiatives reflect the company's interest in pursuing opportunities across several areas of wellness, research and personalized health services.

The Apollo announcement adds a distinct dimension to this strategy: a majority-owned venture focused on medically supervised wellness, telehealth and a planned clinic network.

The potential benefit is the opportunity to build a broader collection of complementary businesses rather than depend on a single product category.

What Investors Will Be Watching Next

With Apollo's strategic foundation now announced, several developments could help demonstrate its progress:
  • Clinic network expansion: Updates on licensed providers, participating locations and the launch of Apollo-branded clinics.
  • Commercial progress: Evidence of growing provider participation and revenue-generating activity.
  • New offerings: Progress toward the planned peptide, nutraceutical and medical-food product lines.
  • Telehealth development: Updates on the expansion and use of Doc-Rx's supporting platform.
  • Financial contributions: Future disclosures clarifying Apollo's operating performance and the contribution of Sibannac's ownership interest.

These milestones could help investors assess how the new venture develops and how it contributes to Sibannac's overall business.

The Bottom Line: A New Chapter of Opportunity for $SNNC

Sibannac's October 27 announcement introduces an important new growth initiative through its 51% majority interest in Apollo Wellness Centers.

With access to Doc-Rx's operating telehealth platform, pharmacy relationships and U.S.-based peptide supply chain, Apollo intends to establish a branded wellness clinic network and explore additional products and services.

The opportunity lies in bringing these capabilities together under one business platform and building a model that can expand through licensed healthcare professionals.

For SNNC shareholders, Apollo represents a development worth watching as Sibannac continues to broaden its wellness portfolio and pursue new avenues for business growth.

The next milestone is execution: establishing the Apollo brand, attracting participating providers, developing clinics and translating the venture's capabilities into measurable commercial progress.

As the company moves forward, additional announcements regarding clinic development, new services and operating performance will help shape the story for investors following Sibannac.

For more information on SNNC visit: www.snncinc.com

Media Contact:

Company Name: Sibannac, Inc.

Contact Person: David Mersky

Email: investors@sibannacinc.com

Phone: (480) 407-6445
Country: United States

DISCLAIMER: https://corporateads.com/disclaimer/

Disclosure listed on the CorporateAds website

Contact
CorporateAds
***@gmail.com


Source: CorporateAds
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Spokane City Council Passes Chronic Nuisance Properties Ordinance
  • City of Spokane and City Council Announce 2027 Legislative Priorities
  • LCH2 Awarded Additional $1 Million to Advance Lewis County Clean Energy Campus
  • Security Planning Tips For Your Holiday Event From Access Patrol Services
  • Tacoma: Council Member Sandesh Sadalge Focuses Today's District 4 Town Hall on the City's Biennial Budget
  • City of Tacoma Awarded $2.25 Million in Federal Highway Safety Improvement Program Grant Funding for South 21st Street Corridor
  • New Self-Service Sandbag Station at Tacoma Recovery and Transfer Center
  • Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
  • Business News & Info Goes Inside Paragon FX Group's Hunt for Original Film Props
  • Kitchen Table Economics: An Invitation to Think Differently
  • Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
  • CB Stuffer Announces Private Sale to Secure Future of Brand Growth
  • The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
  • Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
  • Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
  • TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
  • Spokane: Gesa Pavilion Concert Series Welcomes New Concert Promoter
  • Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
_catLbl0 _catLbl1

Popular on Washingtoner

  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 324
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 281
  • LocalsVoted Launches: Local Rankings From Phone-Verified Votes, Not Paid Placement - 177
  • Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms - 145
  • Sycamore Dove Releases "Loving Every Moment" - 122
  • One in three Americans may have lost track of retirement savings from a previous job - 115
  • Datavalet Named One of Quebec's Best Workplaces™ for 2026 - 111
  • Tacoma: OMWBE Active Certification Class on November 16
  • Nextlink Internet Deploys netElastic to Modernize Its Hybrid Broadband Network
  • ThriveStack citedby launches Prompt Research to find the prompts buyers ask in AI search

Similar on Washingtoner

  • Boston Industrial Solutions Introduces the New Volta® M100 Pad Printing Machine
  • What If the Greatest Gift This Holiday Season Came in a Dream of Your Loved One in Spirit?
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Minneapolis
  • Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
  • UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
  • Green Revolution CBD Spotlights Its Water-Soluble Focus Tincture With CBD, CBG and Lion's Mane
  • Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
  • Coming Up on CNBC: Bilha Wachira Champions Financial Protection During Long-Term Care Awareness Month
  • Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
  • Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute